PMS2 and colorectal carcinoma: Studies in Korea were based on 7 SNPs, including rs10795668, to develop a genetic risk score for prediction and had significant associations with CRC.[28] Win et al[29] observed that heterozygous and homozygous carriers of the G alleles for rs10795668 decreased CRC risk only among PMS2 mutation carriers.